Prevalence of hepatitis C virus antibodies and associated risks among residents in long-term assisted living facilities and shelters in Latvia.

IF 1.5 Q3 GASTROENTEROLOGY & HEPATOLOGY
Clinical and Experimental Hepatology Pub Date : 2024-12-01 Epub Date: 2024-11-20 DOI:10.5114/ceh.2024.144351
Ieva Tolmane, Ieva Siksaliete, Inga Upmace, Inga Bulmistre, Agita Jeruma, Inga Azina, Baiba Rozentale, Raimonds Sīmanis
{"title":"Prevalence of hepatitis C virus antibodies and associated risks among residents in long-term assisted living facilities and shelters in Latvia.","authors":"Ieva Tolmane, Ieva Siksaliete, Inga Upmace, Inga Bulmistre, Agita Jeruma, Inga Azina, Baiba Rozentale, Raimonds Sīmanis","doi":"10.5114/ceh.2024.144351","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim of the study: </strong>This was a retrospective study which aimed to analyse two-year (October 1, 2020 to October 31, 2022) data collected by HIV Prevention Point employees during their routine work and to update hepatitis C virus (HCV) prevalence among residents of long-term assisted living facilities (LTALF) and shelters in Latvia. Key objectives included investigating risk factors associated with HCV infection and analysing demographic characteristics contributing to prevalence.</p><p><strong>Material and methods: </strong>Retrospective analysis of the screening involved 46 LTALF and 6 shelters, randomly selected from Latvia's social service providers register where HCV rapid plasma immunochromatographic antibody tests were used, as well as demographic and risk-related questions asked to participants. Data were recorded, transferred to Google Sheets, and statistically analysed using SPSS software.</p><p><strong>Results: </strong>Out of 2838 tests in LTALF and 349 in shelters, HCV prevalence was 4.2% and 12.0%, respectively. Risk factors such as intravenous narcotic use, incarceration, and unprotected sex were significantly associated with HCV prevalence in both populations. Males had higher prevalence rates than females, particularly in LTALF.</p><p><strong>Conclusions: </strong>The study revealed an HCV prevalence in LTALF almost twice that of the general population and four times higher in shelters. Those denying prior incarceration or intravenous narcotic use still exhibited higher prevalence rates. Significant risk factors included intravenous narcotic use, prior incarceration and unprotected sex. The findings highlight the need for targeted interventions in these high-risk populations and emphasize the importance of tailored prevention, screening, and treatment strategies. The urgency of addressing elevated prevalence rates in LTALF and shelters is underscored, calling for immediate and targeted public health interventions.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"10 4","pages":"271-277"},"PeriodicalIF":1.5000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12022615/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2024.144351","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim of the study: This was a retrospective study which aimed to analyse two-year (October 1, 2020 to October 31, 2022) data collected by HIV Prevention Point employees during their routine work and to update hepatitis C virus (HCV) prevalence among residents of long-term assisted living facilities (LTALF) and shelters in Latvia. Key objectives included investigating risk factors associated with HCV infection and analysing demographic characteristics contributing to prevalence.

Material and methods: Retrospective analysis of the screening involved 46 LTALF and 6 shelters, randomly selected from Latvia's social service providers register where HCV rapid plasma immunochromatographic antibody tests were used, as well as demographic and risk-related questions asked to participants. Data were recorded, transferred to Google Sheets, and statistically analysed using SPSS software.

Results: Out of 2838 tests in LTALF and 349 in shelters, HCV prevalence was 4.2% and 12.0%, respectively. Risk factors such as intravenous narcotic use, incarceration, and unprotected sex were significantly associated with HCV prevalence in both populations. Males had higher prevalence rates than females, particularly in LTALF.

Conclusions: The study revealed an HCV prevalence in LTALF almost twice that of the general population and four times higher in shelters. Those denying prior incarceration or intravenous narcotic use still exhibited higher prevalence rates. Significant risk factors included intravenous narcotic use, prior incarceration and unprotected sex. The findings highlight the need for targeted interventions in these high-risk populations and emphasize the importance of tailored prevention, screening, and treatment strategies. The urgency of addressing elevated prevalence rates in LTALF and shelters is underscored, calling for immediate and targeted public health interventions.

拉脱维亚长期辅助生活设施和庇护所居民中丙型肝炎病毒抗体的流行率及相关风险
研究目的:这是一项回顾性研究,旨在分析艾滋病毒预防点员工在日常工作中收集的两年(2020年10月1日至2022年10月31日)数据,并更新拉脱维亚长期辅助生活设施(LTALF)和避难所居民中的丙型肝炎病毒(HCV)流行情况。主要目标包括调查与丙型肝炎病毒感染相关的危险因素,并分析导致流行的人口统计学特征。材料和方法:回顾性分析筛查涉及46个LTALF和6个避难所,随机选择拉脱维亚社会服务提供者注册,使用HCV快速血浆免疫层析抗体检测,并向参与者询问人口统计学和风险相关问题。记录数据,录入谷歌sheet,用SPSS软件进行统计分析。结果:在LTALF的2838次检测和收容所的349次检测中,HCV患病率分别为4.2%和12.0%。静脉麻醉使用、监禁和无保护的性行为等危险因素与两种人群中的HCV患病率显著相关。男性的患病率高于女性,特别是在ltf。结论:该研究显示,LTALF的HCV患病率几乎是普通人群的两倍,避难所的HCV患病率是普通人群的四倍。否认有过监禁或静脉注射麻醉的人仍然表现出较高的患病率。重要的危险因素包括静脉注射麻醉品使用、先前监禁和无保护的性行为。研究结果强调了对这些高危人群进行有针对性干预的必要性,并强调了量身定制的预防、筛查和治疗策略的重要性。报告强调,迫切需要解决ltf和收容所中发病率升高的问题,呼吁立即采取有针对性的公共卫生干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Experimental Hepatology
Clinical and Experimental Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
2.80
自引率
0.00%
发文量
32
期刊介绍: Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信